A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis Intervention: Biological: CT-P17 SC AI (adalimumab) Sponsors: Celltrion; PPD Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials